| |
 |
Pyrrolo[2,1-c][1,4]benzodiazepine as a Scaffold for the Design and Synthesis of Anti- Tumour Drugs
 |
| |
|
pp.1-31 (31) Authors: Laura Cipolla, Ana C. Araujo, Cristina Airoldi, Davide Bini |
| |
|
|
| |
|
Targeted Small-Molecule Inhibitors of Protein Kinase B as Anticancer Agents
|
| |
|
pp.32-50 (19) Author: Ian Collins |
| |
|
|
| |
|
Targeting the SUMO E2 Conjugating Enzyme Ubc9 Interaction for Anti-Cancer Drug Design
|
| |
|
pp.51-54 (4) Authors: Xinyuan Duan, John O. Trent, Hong Ye |
| |
|
|
| |
|
2-Methoxyestradiol as a Potential Cytostatic Drug in Gliomas?
|
| |
|
pp.55-65 (11) Authors: E. Kirches, M. Warich-Kirches |
| |
|
|
| |
|
Tyrosine Kinase Blockers: New Hope for Successful Cancer Therapy
|
| |
|
pp.66-76 (11) Authors: Dariusz Pytel, Tomasz Sliwinski, Tomasz Poplawski, Deborah Ferriola, Ireneusz Majsterek |
| |
|
|
| |
|
Fused Xanthone Derivatives as Antiproliferative Agents
|
| |
|
pp.77-98 (22) Authors: Nicole Pouli, Panagiotis Marakos |
| |
|
|
| |
|
Radiosensitizing Potential of Epigenetic Anticancer Drugs
|
| |
|
pp.99-108 (10) Authors: Harlinde De Schutter, Sandra Nuyts |
| |
|
|
| |
|
Biotechnological Production of Taxol and Related Taxoids: Current State and Prospects
|
| |
|
pp.109-121 (13) Authors: O. Exposito, M. Bonfill, E. Moyano, M. Onrubia, M. H. Mirjalili, R. M. Cusido, J. Palazon |
| |
|
|
